. 2022 Feb 28;13(3):6024–6035. doi: 10.1080/21655979.2022.2042134
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Figure 1.
TRIM21 is decreased and corrected with poor outcome in OC patients.